HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
Soo‐Yon Rhee(Stanford University), Robert W. Shafer(Stanford University), Jonathan Taylor(Stanford University), Paolo Troia(University of California Davis Medical Center), Vivian Shirvani(Cedars-Sinai Medical Center), W. Jeffrey Fessel(Kaiser Permanente), David R. Kaufman(Gates (United States)), William Towner(Kaiser Permanente), Peter Ruane, Andrew Zolopa(Palo Alto University), James Hellinger(Tufts Medical Center)
Cited by 230
Related Papers
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
|Journal of Clinical Investigation|2017|3.9k
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
|AIDS|2000|1k
Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation
|Clinical Infectious Diseases|2006|666